Rapid diagnostic tests for neurological infections in central Africa

The Lancet Infectious Diseases

Volumn 13, Issue 6, 2013, Pages 546-558

  Yansouni, Cedric P ^a   Bottieau, Emmanuel ^a   Lutumba, Pascal ^b,c   Winkler, Andrea S ^d   Lynen, Lut ^a   Büscher, Philippe ^a   Jacobs, Jan ^a   Gillet, Philippe ^a   Lejon, Veerle ^a   Alirol, Emilie ^e   Polman, Katja ^a   Utzinger, Jürg ^f,g   Miles, Michael A ^h   Peeling, Rosanna W ^h   Muyembe, Jean Jacques ^b,c   Chappuis, François ^e   Boelaert, Marleen ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Institut National de Recherche Biomedicale   (Congo)

^c UNIVERSITY OF KINSHASA   (Congo)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^g UNIVERSITY OF BASEL   (Switzerland)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; AFRICAN TRYPANOSOMIASIS; BACTERIAL MENINGITIS; BRAIN MALARIA; CRYPTOCOCCAL MENINGOENCEPHALITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HERPES SIMPLEX ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; MALARIA; MENINGOENCEPHALITIS; NEUROLOGIC DISEASE; NEUROSCHISTOSOMIASIS; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; REVIEW; SCHISTOSOMIASIS; SERODIAGNOSIS; SYPHILIS; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

AFRICA, CENTRAL; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; HUMANS; INFECTION; MENINGITIS, CRYPTOCOCCAL; NERVOUS SYSTEM DISEASES; TRYPANOSOMIASIS, AFRICAN;

EID: 84878445367     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70004-5     Document Type: Review

References (136)

1. Working to overcome the global impact of neglected tropical diseases: the first WHO report on neglected tropical diseases 2010, WHO, World Health Organization, Geneva.
2. The global burden of disease: 2004 update 2008, WHO, World Health Organization, Geneva.
3. Atlas: country resources for neurological disorders WHO, WFNWFN, (accessed Dec, 31 2011). http://www.who.int/mental_health/neurology/neurogy_atlas_lr.pdf.
4. Urdea M, Penny LA, Olmsted SS, et al. Requirements for high impact diagnostics in the developing world. Nature 2006, 444(suppl 1):73-79.
5. Hotez PJ, Kamath A Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009, 3:e412.
6. Simarro P, Diarra A, Ruiz Postigo J, Franco J, Jannin J The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward. PLoS Negl Trop Dis 2011, 5:e1007.
7. Mitashi P, Hasker E, Lejon V, et al. Human African trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review. PLoS Negl Trop Dis 2012, 6:e1919.
8. Birbeck GL Neurologic disease in a rural Zambian hospital. Trop Doct 2001, 31:82-85.
9. Bower JH, Asmera J, Zebenigus M, Sandroni P, Bower SM, Zenebe G The burden of inpatient neurologic disease in two Ethiopian hospitals. Neurology 2007, 68:338-342.
10. Winkler AS, Mosser P, Schmutzhard E Neurological disorders in rural Africa: a systematic approach. Trop Doct 2009, 39:102-104.
11. Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, Harrison TS Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis 2010, 10:67.
12. Cohen DB, Zijlstra EE, Mukaka M, et al. Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African setting. Trop Med Int Health 2010, 15:910-917.
13. Blum J, Schmid C, Burri C Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta Trop 2006, 97:55-64.
14. Pai NP, Vadnais C, Denkinger C, Engel N, Pai M Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med 2012, 9:e1001306.
15. D'Acremont V, Kahama-Maro J, Swai N, Mtasiwa D, Genton B, Lengeler C Reduction of anti-malarial consumption after rapid diagnostic tests implementation in Dar es Salaam: a before-after and cluster randomized controlled study. Malar J 2011, 10:107.
16. Guidelines for the treatment of malaria 2010, 1-194. WHO, World Health Organization, Geneva. 2nd edn.
17. Yansouni CP, Bottieau E, Chappuis F, et al. Rapid diagnostic tests for a coordinated approach to fever syndromes in low-resource settings. Clin Infect Dis 2012, 55:610-611.
18. Chappuis F, Alirol E, d'Acremont V, Bottieau E, Yansouni CP Rapid diagnostic tests for non-malarial febrile illness in the tropics. Clin Microbiol Infect 2013, published online Jan 17. 10.1111/1469-0691.12154.
19. Nash TE, Garcia HH Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 2011, 7:584-594.
20. Jackson AC Rabies in the critical care unit- diagnostic and therapeutic approaches. Can J Neurol Sci 2011, 38:689-695.
21. Verdonck K, González E, Van Dooren S, Vandamme A-M, Vanham G, Gotuzzo E Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007, 7:266-281.
22. World malaria report 2012 2012, WHO, World Health Organization, Geneva.
23. Murray CJ, Rosenfeld LC, Lim SS, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379:413-431.
24. Taylor SM, Messina JP, Hand CC, et al. Molecular malaria epidemiology: mapping and burden estimates for the Democratic Republic of the Congo, 2007. PLoS One 2011, 6:e16420.
25. Feachem RG, Phillips AA, Hwang J, et al. Shrinking the malaria map: progress and prospects. Lancet 2010, 376:1566-1578.
26. O'Meara WP, Mangeni JN, Steketee R, Greenwood B Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis 2010, 10:545-555.
27. Mishra SK, Newton CR Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol 2009, 5:189-198.
28. Global tuberculosis report 2012 2012, WHO, World Health Organization, Geneva.
29. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009, 59:167-187.
30. Data on the size of the HIV/AIDS epidemic: data by WHO region WHO, (accessed April 2, 2013). http://apps.who.int/gho/data/node.main.619?lang=en.
31. World health statistics 2011 2011, WHO, World Health Organization, Geneva.
32. Jowi JO, Mativo PM, Musoke SS Clinical and laboratory characteristics of hospitalised patients with neurological manifestations of HIV/AIDS at the Nairobi hospital. East Afr Med J 2007, 84:67-76.
33. Vlieghe E, Phoba MF, Tamfun JJ, Jacobs J Antibiotic resistance among bacterial pathogens in Central Africa: a review of the published literature between 1955 and 2008. Int J Antimicrob Agents 2009, 34:295-303.
34. Pelkonen T, Roine I, Cruzeiro M, Pitkäranta A, Kataja M, Peltola H Slow initial β-lactam infusion and oral paracetamol to treat childhood bacterial meningitis: a randomised, controlled trial. Lancet Infect Dis 2011, 11:613-621.
35. Lutumba P, Robays J, Miaka mia Bilenge C, et al. Trypanosomiasis control, Democratic Republic of Congo, 1993-2003. Emerg Infect Dis 2005, 11:1382-1388.
36. Simarro PP, Cecchi G, Franco JR, et al. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl Trop Dis 2012, 6:e1859.
37. Hasker E, Lutumba P, Chappuis F, et al. Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency?. PLoS Negl Trop Dis 2012, 6:e1950.
38. Chappuis F, Lima MA, Flevaud L, Ritmeijer K Human African trypanosomiasis in areas without surveillance. Emerg Infect Dis 2010, 16:354-356.
39. Mumba D, Bohorquez E, Messina J, et al. Prevalence of human African trypanosomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis 2011, 5:e1246.
40. Gryseels B, Polman K, Clerinx J, Kestens L Human schistosomiasis. Lancet 2006, 368:1106-1118.
41. Hürlimann E, Schur N, Boutsika K, et al. Toward an open-access global database for mapping, control, and surveillance of neglected tropical diseases. PLoS Negl Trop Dis 2011, 5:e1404.
42. Carod-Artal FJ Neuroschistosomiasis. Expert Rev Anti Infect Ther 2010, 8:1307-1318.
43. Naus CW, Chipwete J, Visser LG, Zijlstra EE, van Lieshout L The contribution made by Schistosoma infection to non-traumatic disorders of the spinal cord in Malawi. Ann Trop Med Parasitol 2003, 97:711-721.
44. Global incidence amd prevalence of selected curable sexually transmitted infections-2008 2012, WHO, World Health Organization, Geneva.
45. Schmid GP, Stoner BP, Hawkes S, Broutet N The need and plan for global elimination of congenital syphilis. Sex Transm Dis 2007, 34(7 suppl):S5-10.
46. Chico RM, Mayaud P, Ariti C, Mabey D, Ronsmans C, Chandramohan D Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review. JAMA 2012, 307:2079-2086.
47. Data on other STIs: Antenatal care (ANC) attendees tested for syphilis at first ANC visit by country WHO, (accessed April 2, 2013). http://apps.who.int/gho/data/node.main.A1358STI?lang=en.
48. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
49. Ghanem KG Review: neurosyphilis: a historical perspective and review. CNS Neurosci Ther 2010, 16:e157-e168.
50. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010, 10:835-844.
51. Mailles A, Stahl JP Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009, 49:1838-1847.
52. Poissy J, Wolff M, Dewilde A, et al. Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis. Clin Microbiol Infect 2009, 15:560-564.
53. Bissonnette L, Bergeron M Diagnosing infections-current and anticipated technologies for point-of-care diagnostics. Clin Microbiol Infect 2010, 16:1044-1053.
54. Malaria Rapid Diagnostic Test Performance-results of WHO product testing of malaria RDTs: round 3 (2010-2011) WHO, (accessed April 1, 2012). Geneva: World Health Organization; 2011. http://www.who.int/tdr/publications/tdr-research-publications/rdt_round3/en/.
55. Taylor TE, Fu WJ, Carr RA, et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 2004, 10:143-145.
56. Beare N, Taylor T, Harding S, Lewallen S, Molyneux M Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg 2006, 75:790-797.
57. Beare NA, Lewallen S, Taylor TE, Molyneux ME Redefining cerebral malaria by including malaria retinopathy. Future Microbiol 2011, 6:349-355.
58. Shane HL, Verani JR, Abudho B, et al. Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in western Kenya. PLoS Negl Trop Dis 2011, 5:e951.
59. Coulibaly JT, Knopp S, N'Guessan NA, et al. Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Côte d'Ivoire. PLoS Negl Trop Dis 2011, 5:e1384.
60. Lv S, Zhang Y, Steinmann P, Zhou XN, Utzinger J Helminth infections of the central nervous system occurring in Southeast Asia and the Far East. Adv Parasitol 2010, 72:351-408.
61. Lindsley MD, Mekha N, Baggett HC, et al. Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis 2011, 53:321-325.
62. Jarvis JN, Percival A, Bauman S, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis 2011, 53:1019-1023.
63. Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children 2011, WHO, World Health Organization, Geneva.
64. Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 2010, 10:803-812.
65. Lawn SD, Kerkhoff AD, Vogt M, Wood R Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012, 12:201-209.
66. Saha SK, Darmstadt GL, Yamanaka N, et al. Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden. Pediatr Infect Dis J 2005, 24:1093-1098.
67. Moisi JC, Saha SK, Falade AG, et al. Enhanced diagnosis of pneumococcal meningitis with use of the Binax NOW immunochromatographic test of Streptococcus pneumoniae antigen: a multisite study. Clin Infect Dis 2009, 48(suppl 2):S49-S56.
68. Chanteau S, Dartevelle S, Mahamane AE, Djibo S, Boisier P, Nato F New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y. PLoS Med 2006, 3:e337.
69. Boisier P, Mahamane AE, Hamidou AA, et al. Field evaluation of rapid diagnostic tests for meningococcal meningitis in Niger. Trop Med Int Health 2009, 14:111-117.
70. Rose AM, Gerstl S, Mahamane AE, et al. Field evaluation of two rapid diagnostic tests for Neisseria meningitidis serogroup A during the 2006 outbreak in Niger. PLoS One 2009, 4:e7326.
71. Boelaert M, Bhattacharya S, Chappuis F, et al. Evaluation of rapid diagnostic tests: visceral leishmaniasis. Nat Rev Microbiol 2007, 5:S30-S39.
72. Birbeck GL, Beare N, Lewallen S, et al. Identification of malaria retinopathy improves the specificity of the clinical diagnosis of cerebral malaria: findings from a prospective cohort study. Am J Trop Med Hyg 2010, 82:231-234.
73. Hasker E, Mitashi P, Baelmans R, et al. A new format of the CATT test for the detection of human African trypanosomiasis, designed for use in peripheral health facilities. Trop Med Int Health 2010, 15:263-267.
74. Checchi F, Chappuis F, Karunakara U, Priotto G, Chandramohan D Accuracy of five algorithms to diagnose gambiense human African trypanosomiasis. PLoS Negl Trop Dis 2011, 5:e1233.
75. Buscher P, Gilleman Q, Lejon V Rapid diagnostic test for sleeping sickness. N Engl J Med 2013, 368:1069-1070.
76. Tiberti N, Hainard A, Lejon V, et al. Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness. PLoS One 2012, 7:e40909.
77. D'Acremont V, Lengeler C, Mshinda H, Mtasiwa D, Tanner M, Genton B Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever. PLoS Med 2009, 6:e252.
78. D'Acremont V, Malila A, Swai N, et al. Withholding antimalarials in febrile children who have a negative result for a rapid diagnostic test. Clin Infect Dis 2010, 51:506-511.
79. Seydel KB, Fox LL, Glover SJ, et al. Plasma concentrations of parasite histidine-rich protein 2 distinguish between retinopathy-positive and retinopathy-negative cerebral malaria in Malawian children. J Infect Dis 2012, 206:309-318.
80. Dedicoat M, Livesley N Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings). Cochrane Database Syst Rev 2006, 3. CD005420.
81. Swai ES, Schoonman L Seroprevalence of Toxoplasma gondii infection amongst residents of Tanga district in north-east Tanzania. Tanzan J Health Res 2009, 11:205-209.
82. Ndiaye D, Sene PD, Ndiaye M, Faye B, Ndiaye JL, Ndir O Update on toxoplasmosis prevalence based on serological tests in pregnant women in Dakar, Senegal from 2002 to 2006. Med Trop (Mars) 2011, 71:101-102. (in French).
83. Chen R, Lu S, Lou D, et al. Evaluation of a rapid ELISA technique for detection of circulating antigens of Toxoplasma gondii. Microbiol Immunol 2008, 52:180-187.
84. Gray DJ, Ross AG, Li YS, McManus DP Diagnosis and management of schistosomiasis. BMJ 2011, 342:d2651.
85. Gryseels B Schistosomiasis. Infect Dis Clin North Am 2012, 26:383-397.
86. Ferrari TC, Correa-Oliveira R, Xavier MA, Gazzinelli G, Cunha AS Estimation of the local synthesis of immunoglobulin G (IgG) in the central nervous system of patients with spinal cord schistosomiasis by the IgG index. Trans R Soc Trop Med Hyg 1999, 93:558-559.
87. Magalhães-Santos I, Lemaire D, Andrade-Filho A, et al. Antibodies to Schistosoma mansoni in human cerebrospinal fluid. Am J Trop Med Hyg 2003, 68:294-298.
88. Colley DG, Binder S, Campbell C, et al. A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for prevalence of Schistosoma mansoni. Am J Trop Med Hyg 2013, 88:426-432.
89. Corstjens PL, van Lieshout L, Zuiderwijk M, et al. Up-converting phosphor technology-based lateral flow assay for detection of Schistosoma circulating anodic antigen in serum. J Clin Microbiol 2008, 46:171-176.
90. Cryptococcal Antigen Lateral Flow Assay (package insert) 2011, IMMY, Immuno-Mycologics, Norman, OK, USA.
91. Thwaites GE, Tran TH Tuberculous meningitis: many questions, too few answers. Lancet Neurol 2005, 4:160-170.
92. McNerney R, Daley P Towards a point-of-care test for active tuberculosis: obstacles and opportunities. Nat Rev Microbiol 2011, 9:204-213.
93. Patel VB, Singh R, Connolly C, et al. Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting. PLoS One 2010, 5:e15664.
94. Xu HB, Jiang RH, Li L, Sha W, Xiao HP Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis: a meta-analysis. Int J Tuberc Lung Dis 2010, 14:1382-1387.
95. Tuon FF, Higashino HR, Lopes MI, et al. Adenosine deaminase and tuberculous meningitis-a systematic review with meta-analysis. Scand J Infect Dis 2010, 42:198-207.
96. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39:1267-1284.
97. Moosa AA, Ibrahim MD, Quortum HA Rapid diagnosis of bacterial meningitis with reagent strips. Lancet 1995, 345:1290-1291.
98. Molyneux E, Walsh A Caution in the use of reagent strips to diagnose acute bacterial meningitis. Lancet 1996, 348:1170-1171.
99. Bonev V, Gledhill RF Use of reagent strips to diagnose bacterial meningitis. Lancet 1997, 349:287-288.
100. Huy NT, Thao NT, Diep DT, Kikuchi M, Zamora J, Hirayama K Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Crit Care 2010, 14:R240.
101. Karre T, Vetter EA, Mandrekar JN, Patel R Comparison of bacterial antigen test and Gram stain for detecting classic meningitis bacteria in cerebrospinal fluid. J Clin Microbiol 2010, 48:1504-1505.
102. Herring AJ, Ballard RC, Pope V, et al. A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived sera. Sex Transm Infect 2006, 82(suppl 5):v7-12.
103. Mabey D, Peeling RW, Ballard R, et al. Prospective, multi-centre clinic-based evaluation of four rapid diagnostic tests for syphilis. Sex Transm Infect 2006, 82(suppl 5):v13-v16.
104. Castro AR, Esfandiari J, Kumar S, et al. Novel point-of-care test for simultaneous detection of nontreponemal and treponemal antibodies in patients with syphilis. J Clin Microbiol 2010, 48:4615-4619.
105. Castro AR, Mody HC, Parab SY, et al. An immunofiltration device for the simultaneous detection of non-treponemal and treponemal antibodies in patients with syphilis. Sex Transm Infect 2010, 86:532-536.
106. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008, 47:303-327.
107. Lejon V, Ngoyi DM, Ilunga M, et al. Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness. J Clin Microbiol 2010, 48:2836-2839.
108. Gillet P, Ngoyi DM, Lukuka A, et al. False positivity of non-targeted infections in malaria rapid diagnostic tests: the case of human African trypanosomiasis. PLoS Negl Trop Dis (in press).
109. Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000, 28:E63.
110. Matovu E, Kazibwe AJ, Mugasa CM, Ndungu JM, Njiru ZK Towards point-of-care diagnostic and staging tools for human African trypanosomiaisis. J Trop Med 2012, 2012:340538.
111. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377:1495-1505.
112. Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?. J Clin Microbiol 2011, 49:2540-2545.
113. Hillemann D, Rusch-Gerdes S, Boehme C, Richter E Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol 2011, 49:1202-1205.
114. Tortoli E, Russo C, Piersimoni C, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012, 40:442-447.
115. Moure R, Martin R, Alcaide F Effectiveness of an integrated real-time PCR method for detection of the Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples in an area of low tuberculosis prevalence. J Clin Microbiol 2012, 50:513-515.
116. Tyler K Update on herpes simplex encephalitis. Rev Neurol Dis 2004, 1:169-178.
117. Enomoto Y, Yoshikawa T, Ihira M, et al. Rapid diagnosis of herpes simplex virus infection by a loop-mediated isothermal amplification method. J Clin Microbiol 2005, 43:951-955.
118. Kaneko H, Iida T, Aoki K, Ohno S, Suzutani T Sensitive and rapid detection of herpes simplex virus and varicella-zoster virus DNA by loop-mediated isothermal amplification. J Clin Microbiol 2005, 43:3290-3296.
119. Sugiyama H, Yoshikawa T, Ihira M, Enomoto Y, Kawana T, Asano Y Comparison of loop-mediated isothermal amplification, real-time PCR, and virus isolation for the detection of herpes simplex virus in genital lesions. J Med Virol 2005, 75:583-587.
120. Novati R, Castagna A, Morsica G, et al. Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS 1994, 8:1691-1694.
121. Dupon M, Cazenave J, Pellegrin J, et al. Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol 1995, 33:2421-2426.
122. Kettler H, White K, Hawkes S Mapping the landscape of diagnostics for sexually transmitted infections 2004, World Health Organization/Special Programme for Research and Training in Tropical Diseases, Geneva.
123. Mabey D, Peeling RW, Ustianowski A, Perkins MD Diagnostics for the developing world. Nat Rev Microbiol 2004, 2:231-240.
124. Guidelines for assuring the accuracy and reliability of HIV rapid testing: applying a quality system approach 2005, Centers for Disease Control and Prevention and World Health Organization, World Health Organization, Geneva.
125. Moodley D, Moodley P, Ndabandaba T, Esterhuizen T Reliability of HIV rapid tests is user dependent. South Afr Med J 2008, 98:707-709.
126. Mudanyali O, Dimitrov S, Sikora U, Padmanabhan S, Navruz I, Ozcan A Integrated rapid-diagnostic-test reader platform on a cellphone. Lab Chip 2012, 12:2678-2686.
127. Dell NL, Venkatachalam S, Stevens D, Yager P, Borriello G. Towards a point-of-care diagnostic system: automated analysis of immunoassay test data on a cell phone. Proceedings of the 5th ACM workshop on networked systems for developing regions; Bethesda, MD, USA; June 28, 2011. pp 3-8.
128. Learmonth KM, McPhee DA, Jardine DK, Walker SK, Aye TT, Dax EM Assessing proficiency of interpretation of rapid human immunodeficiency virus assays in nonlaboratory settings: ensuring quality of testing. J Clin Microbiol 2008, 46:1692-1697.
129. Gamboa D, Ho MF, Bendezu J, et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One 2010, 5:e8091.
130. Chappuis F, Rijal S, Soto A, Menten J, Boelaert M A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ 2006, 333:723.
131. Hürlimann E, Schur N, Boutsika K, et al. Toward an open-access global database for mapping, control, and surveillance of neglected tropical diseases. PLoS Negl Trop Dis 2011, 5:e1404.
132. Cecchi G, Paone M, Franco JR, et al. Towards the atlas of human African trypanosomiasis. Int J Health Geogr 2009, 8:15.
133. Simarro PP, Cecchi G, Paone M, et al. The atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr 2010, 9:57.
134. Simarro PP, Franco JR, Cecchi G, et al. Human African trypanosomiasis in non-endemic countries (2000-2010). J Travel Med 2012, 19:44-53.
135. Hay S, Snow R The Malaria Atlas Project: developing global maps of malaria risk. PLOS Med 2006, 3:e473.
136. Nkengasong JN, Nsubuga P, Nwanyanwu O, et al. Laboratory systems and services are critical in global health: time to end the neglect?. Am J Clin Pathol 2010, 134:368-373.